Noqturina (Desmopressin)

Desmopressin mimics the natural hormone vasopressin and binds selectively to V2 receptors in the kidney collecting ducts. This activation raises intracellular cAMP, causing aquaporin‑2 channels to move to the cell surface, which increases water reabsorption and concentrates urine. In hemostasis, it stimulates endothelial cells to release von Willebrand factor and factor VIII.

The appropriate dose of Noqturina is individualized by the prescribing healthcare professional based on the patient’s age, weight, renal function, severity of the condition, and response to therapy. No standard dosing regimen is provided here; the prescriber will set the exact amount and frequency.

Safety data for desmopressin during pregnancy and lactation are limited. It should only be used when the potential benefit justifies any potential risk to the fetus or infant. Healthcare providers will evaluate the risk‑benefit profile for each patient and advise accordingly.

To order Noqturina, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the request, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any necessary import documentation.

The primary alternative to desmopressin is natural vasopressin (Pitressin) or older antidiuretic agents such as chlorpropamide. Desmopressin offers a longer half‑life, greater selectivity for V2 receptors, and a lower risk of vasoconstrictive side effects compared with vasopressin, while providing more predictable antidiuretic and hemostatic effects than chlorpropamide.

Noqturina should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging to protect it from moisture and light. Do not store in a refrigerator or freezer unless the manufacturer specifies otherwise.

Noqturina is taken orally, usually with a glass of water. The tablet or oral solution should be swallowed whole unless the prescriber advises otherwise. It may be taken with or without food, but patients should follow the specific instructions provided by their healthcare professional.

The most serious risks include severe hyponatremia, which can lead to seizures, coma, or death, and water intoxication resulting in cerebral edema. Patients should be alert for sudden headache, nausea, vomiting, confusion, or swelling, and should seek immediate medical attention if these symptoms occur.

Noqturina is contraindicated in individuals with known hypersensitivity to desmopressin or any component of the formulation, in patients with uncontrolled hyponatremia, and in those with severe renal impairment where water balance cannot be safely managed. It should also be avoided in patients taking other potent antidiuretic agents unless specifically directed by a physician.